Leave Your Message

Submit An Free Inquiry

Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

AI Helps Write
AI Helps Write

Ciwon sankarar lymphoblastic mai tsanani (T-ALL)-05

Majiyyaci: Ba a san ko wanene ba

JinsiNamiji

Shekaru: shekaru 15

Ƙasa: Sinanci

Ganewar GanewaCiwon sankarar lymphoblastic mai tsanani (T-ALL)

    Gyaran Marasa Lafiyar T-ALL Mai Lalacewa Da Ciwon Jijiyoyin Tsakiyar Jijiyoyi Bayan Maganin CAR-T


    Wannan lamari ya shafi wani yaro ɗan shekara 16 daga Arewa maso Gabashin China, wanda tafiyarsa da cutar sankarar jini ta cika da ƙalubale tun bayan gano cutar a cikin shekara guda da ta gabata.


    A ranar 8 ga Nuwamba, 2020, Dawei (wani sunan barkwanci) ya ziyarci wani asibiti na yankin saboda taurin fuska, kuraje, da kuma bakin da ya karkace. An gano yana da "cutar sankarar lymphoblastic mai tsanani (nau'in ƙwayoyin T)." Bayan wani kwas na maganin chemotherapy na induction, MRD (ƙaramin cutar da ta rage) ba ta da cutar, sai kuma maganin chemotherapy na yau da kullun. A wannan lokacin, huda ƙashi, huda ƙashi, da allurar ciki ba su nuna wata matsala ba.


    A ranar 6 ga Mayu, 2021, an yi huda a lumbar tare da allurar intrathecal, kuma binciken ruwan cerebrospinal (CSF) ya tabbatar da "leukemia na tsarin jijiyoyi na tsakiya." Bayan haka, an yi amfani da nau'i biyu na chemotherapy akai-akai. A ranar 1 ga Yuni, an yi huda a lumbar tare da nazarin CSF ya nuna ƙwayoyin da ba su kai ba. An yi ƙarin huda a lumbar guda uku tare da allurar intrathecal, inda gwajin ƙarshe na CSF bai nuna ƙwayoyin ƙari ba.


    A ranar 7 ga Yuli, Dawei ya fuskanci matsalar gani a idonsa na dama, wanda ya ragu zuwa haske kawai. Bayan wani gwaji na musamman na maganin chemotherapy, hangen idonsa na dama ya koma daidai.


    A ranar 5 ga Agusta, ganin idonsa na dama ya sake tabarbarewa, wanda hakan ya haifar da makanta gaba ɗaya, kuma idonsa na hagu ya yi duhu. Daga 10 zuwa 13 ga Agusta, an yi masa aikin radiotherapy na kwakwalwa da kashin baya (TBI), wanda ya dawo masa da gani a idonsa na hagu, amma idonsa na dama ya kasance makaho. A ranar 16 ga Agusta, an yi gwajin MRI na kwakwalwa ya nuna ɗan ci gaba a cikin kauri na jijiyar gani ta dama da kuma chiasm, tare da lura da ƙarin girma. Ba a sami wata alama ko ƙarin ci gaba ba a cikin parenchyma na kwakwalwa.


    A wannan lokacin, iyalin sun shirya don dashen ƙashi, suna jiran gado kawai a sashen dashen. Abin takaici, gwaje-gwajen da aka yi kafin dashen sun nuna matsalolin da suka sa dashen ba zai yiwu ba.

    2219

    A ranar 30 ga watan Agusta, an yi huda kasusuwa, inda aka gano MRD na bargon kasusuwa tare da ƙwayoyin T marasa kyau waɗanda suka kai 61.1%. An kuma yi huda kasusuwan lumbar tare da allurar ciki, wanda ya nuna CSF MRD tare da jimillar ƙwayoyin halitta 127, waɗanda daga cikinsu ƙwayoyin T marasa kyau waɗanda ba su kai ba sun ƙunshi 35.4%, wanda ke nuna sake dawowar cutar sankarar jini gaba ɗaya.

    A ranar 31 ga Agusta, 2021, Dawei da iyalinsa sun isa cibiyarmu ta CGT. Gwaje-gwajen jinin da aka yi musu sun nuna: WBC 132.91×10^9/L; bambancin jinin gefe (morphology): 76.0% fashewa. An yi amfani da maganin chemotherapy na induction a cikin kwas ɗaya.

    Bayan duba maganin da Dawei ya yi a baya, ya bayyana cewa T-ALL ɗinsa ya yi tsauri/ya koma baya kuma ƙwayoyin ciwon sun shiga kwakwalwa, wanda hakan ya shafi jijiyar gani. Ƙungiyar likitoci ta gano cewa Dawei ya cika sharuɗɗan shiga gwajin asibiti na CD7 CAR-T.

    A ranar 18 ga Satumba, an sake yin wani gwaji: bambancin jinin gefe (morphology) ya nuna fashewar 11.0%. An tattara ƙwayoyin lymphocytes na jini na gefe don haɓaka ƙwayoyin CD7 CAR-T a rana ɗaya, kuma aikin ya tafi cikin sauƙi. Bayan tattarawa, an ba da chemotherapy don shirya don maganin rigakafi na ƙwayoyin CD7 CAR-T.

    A lokacin da ake amfani da maganin chemotherapy, ƙwayoyin ƙari sun yi yawa cikin sauri. A ranar 6 ga Oktoba, bambancin jini (morphology) ya nuna fashewar jini da kashi 54.0%, kuma an daidaita tsarin chemotherapy don rage nauyin ƙari. A ranar 8 ga Oktoba, wani bincike kan ƙwayoyin ƙashi ya nuna fashewar 30.50%; MRD ya nuna cewa kashi 17.66% na ƙwayoyin halitta ƙwayoyin T ne masu cutarwa waɗanda ba su kai ba.

    A ranar 9 ga Oktoba, an sake haɗa ƙwayoyin CD7 CAR-T. Bayan sake haɗawa, majiyyacin ya sake fuskantar zazzaɓi da ciwon ɗanko. Duk da ƙarin maganin hana kamuwa da cuta, zazzaɓin bai yi tasiri sosai ba, duk da cewa ciwon ɗanko ya ragu a hankali.

    A rana ta 11 bayan sake haɗawa, fashewar jini a gefen jiki ta ƙaru zuwa kashi 54%; a rana ta 12, gwajin jini ya nuna ƙwayoyin jinin fari suna ƙaruwa zuwa 16×10^9/L. A rana ta 14 bayan sake haɗawa, majinyacin ya kamu da CRS mai tsanani, ciki har da lalacewar zuciya, matsalar hanta da koda, ƙarancin iskar oxygen, zubar jini a cikin hanji, da kuma suma. Magunguna masu tsanani da kuma tallafi, tare da musayar jini, sun inganta aikin gabobin da abin ya shafa a hankali, suna daidaita alamun lafiyar majinyacin.

    A ranar 27 ga Oktoba, majinyacin yana da ƙarfin tsoka mai maki 0 ​​a ƙananan gaɓoɓin biyu. A ranar 29 ga Oktoba (kwana 21 bayan sake haɗawa), gwajin MRD na ƙashi ya koma mara kyau.

    A cikin yanayin sassaucin rashi, Dawei ya ƙarfafa aikin ƙananan gaɓoɓinsa tare da taimakon ma'aikatan jinya da iyali, a hankali ya dawo da ƙarfin tsoka zuwa maki 5. A ranar 22 ga Nuwamba, an mayar da shi sashen dashen don shirya wa dashen ƙwayoyin halittar jini na allogeneic.

    bayanin2

    Submit An Free Inquiry

    Our medical team will make an evaluation for you, based on the information you provided. This procedure is free of charge.

    AI Helps Write